RNA Clinical Trials Resources

31. Writing Effective Clinical Regulatory Documents For Therapy Trials 7/11/2025

    Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.

32. Dispelling Common Clinical Trial Oversight Myths 6/17/2025

    Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.

33. Optimizing Clinical Data: Reducing Redundancy For Efficiency 6/6/2025

    Enabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.

34. Top Biotech Hubs Around The World: Where Innovation Thrives In 2025 5/20/2025

    Explore the leading biotech hubs in 2025, what makes them unique, and how companies can leverage these ecosystems to accelerate innovation and growth.

35. Overview Of Obesity: Global Clinical Trials Landscape 5/20/2025

    This comprehensive overview of current and emerging obesity treatments provides insight into the growing global health crisis that is rising in prevalence across all demographics and income levels.

36. IPF - Global Clinical Trial Landscape 5/19/2025

    This report provides a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal interstitial lung disease.

37. Overview Of Idiopathic Pulmonary Fibrosis: Global Clinical Trials Landscape 5/14/2025

    Explore the growing number of clinical trials and innovative approaches for Idiopathic Pulmonary Fibrosis (IPF) treatments.

38. Infectious Diseases - Global Clinical Trial Landscape (2025) 5/14/2025

    The global infectious disease clinical trial landscape has rapidly expanded between 2020 and 2024, driven by the urgency of emerging threats, technological innovation, and evolving regulatory frameworks.

39. Obesity - Global Clinical Trial Landscape (2025) 5/14/2025

    This report analyzes the current state of global and Asia-Pacific obesity trials, highlighting regional trends, sponsor activity, and preferred endpoints.

40. Complexing RNPs: Have You Established Your Clinical Acceptance Criteria? 5/13/2025

    When using CRISPR-Cas proteins for gene editing, it’s critical to ensure consistency and quality at each stage of the manufacturing process. The FDA recommends establishing well-defined acceptance criteria for the RNP formation step.